Boost for patients with life-threatening conditions who require access to medicines not yet authorised for marketing
Updated Date: Tue, 25 Jan 2022 00:00:00 EST
Updated Date: Tue, 25 Jan 2022 00:00:00 EST
Updated Date: Tue, 25 Jan 2022 00:00:00 EST
Updated Date: Tue, 25 Jan 2022 00:00:00 EST
Updated Date: Tue, 25 Jan 2022 00:00:00 EST
We went to the cinema last week. Hardly something to write about. But this was different. It was […]
Yesterday saw the publication of the Lancet Commission on the Value of Death: Bringing Death Back Into Life.1 […]
How did UCB close its $1.9 billion deal to buy Zogenix and its key epilepsy drug? SEC filing […]
